Recent advances in high-throughput technologies have created exciting opportunities for systematically investigating the molecular basis of human disease. In addition to a growing catalog of disease-associated genetic variations, we can now map out an increasingly detailed network diagram of the complex machinery of interacting molecules that constitutes the basis of (patho-) physiological states. The emerging field of 'network medicine' applies tools and concepts from network theory to interpret this diagram and elucidate the relation between perturbations on the molecular level and phenotypic disease manifestations. The interactome, i.e. the integrated network of all physical interactions within the cell, can be interpreted as a map and diseases as local perturbations. Network-based approaches can aid in identifying the specific interactome neighborhood that is perturbed in a certain disease, guide the search for therapeutic targets and reveal common molecular mechanisms between seemingly unrelated diseases.
Introduction
The Online Mendelian Inheritance in Man (OMIM) database [1] currently lists over 3700 genes with mutations that are known to have a phenotypic impact, e.g. sequence alterations that are causal for Mendelian diseases or variants that increase the susceptibility to complex diseases or cancer. Yet, despite this ever growing wealth of data, many details of how exactly genetic alterations contribute to the disease pathobiology remain in the dark. A crucial roadblock for translating gene-level discoveries into a mechanistic understanding of disease pathogenesis and concrete strategies for prevention, diagnosis, and treatment is that gene products do not act in isolation, but in the context of other genes and proteins. Biological processes are ultimately the result of a highly dynamic and regulated interplay of macromolecules, such as interactions between proteins or between proteins and DNA or RNA. The entirety of all such biologically relevant interactions form a large and highly connected network, often referred to as the 'interactome' (Box 1). The interactome can therefore be understood as a map to investigate how individual (or several) genetic alterations propagate throughout the network and perturb the system as a whole. The emerging field of 'network medicine' applies tools and concepts from network theory (Box 2) to interpret this map and elucidate the relation between perturbations on the molecular level and phenotypic disease manifestations [2] . In the last decade, network-based approaches have been successfully applied to a broad range of diseases, with examples ranging from rare Mendelian disorders [3] , cancer [4] or metabolic diseases [5] , to identifying basic strategies by which viruses hijack the host interactome [6] , to name but a few. In the following we will review the basic ideas that underly interactome-based approaches to human disease and highlight important recent conceptual advances.
The interactome
The term 'interactome' is only loosely defined and may refer to networks that contain rather different types of interactions. It is instructive to distinguish between physical and functional interactions. Physical interactions involve actual physical contact between the participating biomolecules, for example proteins that assemble in a complex or receptor-ligand binding. Functional interaction, on the other hand, can refer to any kind of biologically relevant relationship. In co-expression networks, for example, genes are connected if their expression patterns are strongly correlated [7] . Another important functional relationship are 'genetic interactions', where two genes are linked if the effect of a simultaneous alteration of both genes differs from the expectation based on the individual alterations. An extreme form is synthetic lethality, where a combined loss of two genes leads to cell death, while the loss of each individual gene does not [8] . Synthetic viability, conversely, occurs when the lethal effect of a mutation in one gene is rescued by a simultaneous mutation in a second gene [9] . While both functional and physical interaction networks can yield important insights into disease mechanisms, we will focus mostly on the more narrowly defined physical interactions in the following.
A number of publicly available databases provide comprehensive lists of physical proteineprotein interactions (PPIs), as well as other relevant interactions (e.g. protein-DNA, protein-RNA, enzyme-metabolite) in human, but also in other species [10] . There are three main sources for the PPIs reported therein: (i) interactions curated from the scientific literature and typically derived from small-scale experiments. (ii) Interactions from systematic, proteome-scale mapping efforts, the two main techniques being yeast two-hybrid assays for binary interactions [11] 
Disease modules in the interactome
Among the first evidence for a direct correspondence between the biological importance of a gene and the interactome position of its product was the observation that the phenotypic impact of deleting a gene in the yeast Saccharomyces cerevisiae correlates with the number of interaction partners of the corresponding protein [17] . This trend was later confirmed also for genes that are essential for the viability of human cell lines [18] . The topological properties of disease-associated genes are generally more diverse and may differ between disease classes (e.g. complex diseases, Mendelian diseases or cancer), as well as inheritance modes (autosomal dominant or recessive): cancer driver genes generally show a strong tendency towards high network centrality (Box 2), while recessive disease genes are often more isolated and located at the periphery of the interactome [19] .
To further elucidate the detailed mechanisms, by which a disease-associated perturbation contributes to the pathobiological phenotype, it is important not only to understand the network properties of individual associated genes, but also their interactome environment and emerging collective properties. This is particularly evident for complex diseases that involve potentially hundreds of genes. Similar to the functional coherence of interactome neighbors (i.e., interacting proteins are often involved in the same biological process [20] ), Box 2. Basic topological characteristics of networks.
The degree of a node is the number of links attached to it, i.e. the number of direct neighbors. The distribution of the degrees across all nodes is an important global characteristic of a network.
Scale free networks are characterized by a heterogeneous degree distribution that follows a power-law: while most nodes have only few neighbors, there are also a few highly connected 'hubs' with a large number of neighbors.
A path between two nodes is a sequence of links connecting the two. The minimum number of links needed to connect the two is called 'shortest path length' and represents their 'network distance'.
Centrality measures exist for both nodes and for links and quantify their topological importance within the network. There are different types of centrality measures, e.g. the 'degree centrality' (simply given by the degree) or 'betweenness centrality' (quantifying how many shortest paths of the full network cross through a certain node).
Clustering describes a tendency observed in many biological (and other) networks that two neighbors of a node are often also connected to each other, thus forming a triangle.
Motifs are small recurrent subgraphs in a network that occur particularly frequently.
Network communities are groups of tightly interconnected nodes that have more connections among themselves than to the rest of the network.
genes associated with the same disease have been found to interact with each other more frequently than expected by chance [21] . This observation has been verified systematically for a large number of diseases [16] , thus confirming a fundamental hypothesis of interactome-based approaches to human disease, namely that disease genes tend to cluster within socalled disease modules. Such disease modules are connected subgraphs of the interactome that contain all molecular determinants of a certain disease. The first step towards elucidating the biological mechanisms of a disease in a network-based framework is therefore to identify the respective disease module.
Interactome-based gene prioritization
In recent years, a plethora of disease-module identification methods have been proposed that explore the local network neighborhood around known diseaseassociated genes ('seed genes') to infer likely new disease gene candidates [22] . They can roughly be classified into three main categories: (i) Path-based approaches consider the genes along the shortest paths between the known disease genes as potential candidate genes. These candidate genes can then be further ranked, for example according to the number [23] or significance [24] of paths they participate in, or filtered such that they form a minimal connected subgraph, a so-called Steiner-tree [25] . (ii) Dynamical approaches aim to identify candidate genes by propagating known disease associations using dynamical models, for example diffusive processes, where the network neighborhood around seed genes is scanned by simulating random walks along the links [26e29] . Genes that are visited more frequently are considered dynamically closer to the seed genes and therefore ranked higher. (iii) Connectivity-based approaches algorithms rank candidate genes according to their number of links to seed genes [30e32].
Relationship between diseases
Considering the highly connected interactome, it is apparent that diseases can rarely be understood as independent entities. Uncovering such relationships between diseases systematically can help us understand how different pathological phenotypes are linked together at the molecular level and shed light on disease comorbidity, i.e. the observation that certain groups of diseases frequently arise together [33] . Indeed, a largescale evaluation of shared gene associations revealed a highly connected 'diseaseome', in which more than 500 diseases form a giant component and more than 800 diseases have at least one link to another disease [34] . Other diseaseedisease networks have been constructed based on shared metabolic pathways [35] , phenotype similarity [36, 37] , the structure of disease ontologies [38] or comorbidity extracted from patient records [39, 40] . In an interactome-based framework, the relationship between two diseases is represented by overlapping disease modules, indicating that perturbations causing one disease are likely to also affect the other disease. A systematic study of over 44,000 disease pairs revealed that the degree of this overlap is highly predictive for the pathobiological similarity of diseases, such that diseases with overlapping modules show significant co-expression patterns, symptom similarity, and comorbidity, while those that reside in separated interactome neighborhoods are pathobiologically and clinically distinct [16].
The considerable molecular-level overlap that has been observed for many diseases pinpoints a limitation of canonical disease classifications that, historically, are largely based on clinicopathological evidence and often categorized according to the organ system that the disease primarily affects. Interactome-based methodologies could provide a more holistic framework for disease classification based on molecular mechanism [41] .
Tissue-specific interactomes
The studies discussed above considered an integrated interactome containing interactions that have been identified using various techniques and were observed under different experimental and biological conditions. While such a global interactome provides invaluable information for discovering general principles of diseaseassociated network perturbations, it cannot account for the cell-type or tissue-specific manifestations that characterize many diseases. Directly measured contextspecific interactome networks are scarce, but can be approximated by integrating more widely available transcriptome or proteome information [42, 43] . The main idea is to use tissue-specific expression information to filter the global interactome for interactions that are feasible in a given tissue, i.e. both interaction partners are present [44] . Consequently, the resulting tissue-specific interactomes are generally smaller and sparser. In line with the observation that essential genes are more central in the global interactome, genes that are expressed across many tissues (such as 'housekeeping' genes) were found to form a core interactome to which the more tissue-specific genes then attach, thus forming tissue-specific peripheries [45e47] . A comparison between the global and tissue-specific interactomes further revealed that diseases typically manifest in those tissues, in which the corresponding disease-module is least fragmented [48] . Tissue-specific interactome networks can therefore shed light onto the detailed disease-associated rewiring events [49, 50] and considerably improve disease gene prioritization [47, 51, 52] .
Drugs in the interactome
From a network-based perspective, the action of drugs can be interpreted similarly to the effect of disease-associated genetic variants, i.e. as a local perturbation of the interactome. Many of the concepts and tools introduced above can be therefore immediately applied in the context of network pharmacology [53, 54] . Several studies of drug-target networks have shown that most currently used drugs are less selective than previously assumed and instead target multiple proteins [55, 56] . These target proteins tend to be more highly connected than random proteins, but less so than essential proteins. Most drugs do not target the corresponding disease module as a whole, but only a small subset or adjacent interactome neighborhood [57] . It was further found that drugs whose affected interactome neighborhood is closer to the disease module tend to be more effective in the clinic. These insights could help in selecting the most promising drug targets, for example by prioritizing targets according to their topological properties [58] , as well as in designing multitarget drugs that act specifically and directly on the respective disease module [54] . Another promising application of interactome-based drugedisease relationships are approaches to drug repurposing, for example by systematically identifying diseases with shared molecular mechanism that may be modulated by the same therapeutic intervention [59] .
Conclusion
Interactome-based approaches to human disease have matured considerably in the past few years, now possessing both a firm theoretical fundament, as well as a broad range of successful applications across all major areas of human disease research. At the same time, the interactome represents only one layer of relevant information. A pressing challenge on the way towards the next generation of (network) medicine is to integrate the ever growing amount of omics data (e.g., genomics, epigenomics, proteomics, metabolomics, lipidomics). Interactome-based, and more generally, network-based approaches are inherently holistic and integrative, thus offering unique opportunities in this endeavor.
Glossary
Interactome A global network representing all molecular interactions in a cell. In most cases, the term specifically refers to physical interaction networks consisting mostly of proteineprotein interactions, but also of protein-DNA or protein-RNA interactions. More generally, the term interactome may also be used to describe functional interactions, such as genetic interactions. Disease Gene Gene with a known disease association. Sometimes the term is reserved to genes with a known mutant genotype that causes an inherited disorder. More generally, the term is used also for genes containing a risk variant for complex diseases or other, more indirect associations to a particular disease.
Candidate gene Gene with suspected role in the pathobiology of a disease based on prior evidence. . A thorough investigation of the topological interactome properties of disease genes for different classes of diseases and inheritance modes, offering a much more diverse picture than previously appreciated that can also explain apparent contradictions in the literature.
